← All indications
Critical Illness
A disease or state in which death is possible or imminent.
Drugs by status
Phase 4 trials (63)
- levofloxacin
- melatonin
- propofol
- vitamin d3
- ceftaroline fosamil
- linezolid
- ambroxol
- acetylcysteine
- urea
- cefotaxime
- ketamine
- cilastatin
- cisatracurium
- oxycodone
- l-glutamine
- albumin (Human)
- insulin human
- esketamine
- daptomycin
- magnesium oxide
- caspofungin
- metoclopramide
- nystatin
- vitamin c
- piperacillin
- acetaminophen
- potassium chloride
- magnesium sulfate
- lidocaine
- lactoferrin
- +33 more
Phase 3 trials (33)
- simvastatin
- ringer's lactate
- maltodextrin
- heparin
- vitamin e
- tobramycin
- Bismuth Subcitrate Potassium
- norepinephrine
- haloperidol
- hydrocortisone
- etomidate
- lorazepam
- naloxegol
- nefopam
- cow milk
- propranolol
- prucalopride succinate
- red blood cells
- hyaluronic acid
- sitagliptin
- levobupivacaine
- acetylsalicylic acid
- glucose
- spironolactone
- azithromycin
- morphine
- dapagliflozin
- monosodium glutamate
- sargramostim
- polymyxin b sulfate
- +3 more
Phase 2 trials (43)
- montelukast
- metronidazole
- denosumab
- beta-hydroxyisovaleric acid
- epoetin
- cefazolin
- clevidipine
- fludrocortisone
- aciclovir
- guanfacine
- rosuvastatin
- ganciclovir
- inulin
- iron dextran
- metolazone
- oseltamivir
- pectin
- ticagrelor
- prasugrel
- testosterone
- valaciclovir
- valganciclovir
- calcitriol
- zoledronic acid
- nandrolone phenpropionate
- autologous microbiome
- glucagon-like peptide-1
- tak-954
- zinc dichloride
- methadone
- +13 more
Phase 1 trials (7)
Other trials (42)
- 99mtc-rhenium sulfide
- porcine brain-derived peptide preparation
- empagliflozin
- gabapentin
- insulin glargine
- glycopyrronium
- remdesivir
- bone marrow derived mesenchymal stem cells
- sodium oxybate
- bovine colostrum
- tigecycline
- insulin degludec
- iohexol
- whey protein
- itropride
- kefir
- silver nanoparticles
- rocuronium
- tocilizumab
- ulinastatin
- xuebijing
- amphotericin b
- bifidobacterium bifidum
- lactobacillus fermentum
- medium chain triglyceride
- gentamicin
- neostigmine
- ferritin
- transferrin
- ly2787106
- +12 more
Organizations
Organization Involved with Phase 4 Indications (61)
- Fresenius
- AstraZeneca
- Pfizer
- Cubist
- GlaxoSmithKline
- Hamilton Health Sciences Corporation
- The Foundation Institute San Raffaele G. Giglio of Cefalù
- National Heart, Lung, and Blood Institute (NHLBI)
- Institut d'Investigació Biomèdica de Girona Dr. Josep Trueta
- University of Arizona
- Cairo University
- Chang Gung University
- Cornell University
- Duke University
- Hospital Sao Domingos
- Katholieke Universiteit Leuven
- King Edward Medical University
- Mahidol University
- McMaster University
- Onze Lieve Vrouw Hospital
- Sichuan University
- Universidad Autonoma de Madrid
- University of Groningen
- University of Kentucky
- University of Maryland
- University of Michigan
- University of Milan
- University of Tennessee
- University of Alberta
- University of Bari
- +31 more
Organization Involved with Phase 3 Indications (65)
- Hamad Medical Corporation
- The EMMES Corporation
- Swiss National Science Foundation
- ZonMw: The Netherlands Organisation for Health Research and Development
- National Institutes of Health (NIH)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Shahid Beheshti University of Medical Sciences
- Medical University of Graz
- Ain Shams University
- Canadian Critical Care Trials Group
- Case Western Reserve University
- University of London
- Harvard University
- Emory University
- Federal University of Rio Grande do Sul
- Hôpital Raymond Poincaré
- Hospital do Coracao
- Hospital Moinhos de Vento
- Hospital Nossa Senhora da Conceicao
- Hospital Sirio-Libanes
- King Faisal University
- Makerere University
- Queen's University, Belfast
- Universidad de Murcia
- Thomas Jefferson University
- University of Edinburgh
- University of Lausanne
- University of Manchester
- University of Ottawa
- University of Puerto Rico
- +35 more
Organization Involved with Phase 2 Indications (50)
- Theravance
- Millennium Pharmaceuticals
- Novo Nordisk
- Beijing Institute of Pharmacology and Toxicology
- Leading BioSciences, Inc
- Ortho Biotech, Inc.
- Fundación Cardiovascular de Colombia
- Centers for Disease Control and Prevention, China
- Medical Research Council
- National Institute of Allergy and Infectious Diseases (NIAID)
- Brigham and Women's Hospital
- University of Pennsylvania
- Barwon Health
- Damanhour University
- Johns Hopkins University
- Medical University Innsbruck
- Melbourne Health
- Monash University
- Nanjing University
- Newcastle University
- Ohio State University
- Sanford Health
- Rutgers University
- University of Malaya
- University of Melbourne
- University of Southern California
- University of Sydney
- University of Birmingham
- Wake Forest University
- Yale University
- +20 more
Organization Involved with Phase 1 Indications (13)
Organization Involved with Other Experimental Indications (46)
- Abbott
- Yabao Pharmaceutical Group
- National Nutrition and Food Technology Institute
- Ziekenhuis Oost-Limburg
- Aarhus University
- CAMC Health System
- McGill University
- Menoufia University
- Northwell Health
- Postgraduate Institute of Medical Education and Research
- Texas A&M University
- University of Louisville
- West Virginia University
- Tel Aviv University
- Dalian Medical University
- All India Institute of Medical Sciences
- Jiao Tong University
- University of Angers
- University of Malawi
- University of Montpellier
- St. Antonius Hospital, Nieuwegein
- St Eloi University Hospital
- National Taiwan University
- Karolinska Institute
- Government of Pakistan
- University of Hasanuddin
- University of Lyon
- Henan Medical University
- Jawaharlal Institute of Postgraduate Medical Education and Research
- University of Ostrava
- +16 more